VX-765 treatment reduced full-length Casp1 levels slightly compared to vehicle-treated J20 mice, but this did not reach statistical significance.
← all excerpts
Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging.
1
—
—